Topical Version Could Expand Botox, Dysport’s Popularity The number of applications for botulinum toxin continues to grow, even in aesthetic medicine, where you might assume the drug has reached its peak in popularity.
Image Courtesy of Allergan Inc
An article from CBS Interactive Business Network
, says that Medicis, maker of Dysport, is working with a company called Revance to create a topical – “wipe-on, wipe-off” –application of botulinum toxin for the treatment of facial lines and wrinkles.
Meanwhile, Allergan (maker of Botox
) is researching the drug for therapeutic uses for pain relief, juvenile cerebral palsy and enlarged prostate. In October of last year, Botox was FDA approved as a preventive treatment for chronic migraine.
Of course, Allergan continues to focus on the drug’s success as a wrinkle filler. On their redesigned website, users are able to upload their own photos and run them through a visualizer, which shows what they might look like after Botox injection.
National sales of Botox began recovering last year after a decline during the 2008 economic recession. Recent statistics from the ASPS show a modest increase in non-surgical cosmetic procedures (including Botox) from 2009 to 2010.
Dysport, released by Medicis in 2009, has also seen its own success in the market. Medicis’ non-acne skin products were up more than 30 percent in 2010, and most of that increase is probably owed to Dysport sales.